MaxCyte ExPERT GTx scalable electroporation system

The ExPERT GTx electroporation technology is capable of high-performance delivery of virtually any molecule, into any cell, at any scale with the unique ability to transfect primary cells, stem cells and cell lines with minimal disturbance resulting in transfection efficiencies routinely ≥90%.

It represents the next generation of the industry’s leading, clinically validated and scalable electroporation technology for complex cellular engineering.

  • Rapidly transfect from 75 thousand to 20 billion cells
  • 21CFR Part 11 enabled software
  • Established regulatory path supported by FDA Master File
  • Closed, cGMP compliant system
  • MaxCyte’s proprietary Flow Electroporation™ Technology

The ExPERT GTx provides enhancements that improve ease of use, processing workflow, regulatory compliance, and overall user experience with its elegant design that fits seamlessly into any high-tech laboratory space.

  • Integrated Touch-Screen – easy operation with a touch of a finger
  • Enhanced Software User Interface – upgraded, 21 CFR Part 11 enabled software provides additional regulatory compliant functionality and intuitive ease of use
  • LED Status Indicators – 6 colorful and clearly defined status modes provide the user with a quick way to visualize instrument and run status
  • Barcode Reader – capture important sample processing details and minimize manual information entry to improve overall sample, reagent and Processing Assembly traceability
  • Retractable Bag Hooks – easily available when needed for large volume processing and then fold away when not in use
  • Reduced Footprint – industry’s leading transfection processing capacity in a small footprint – maximizes productivity while saving valuable laboratory counter space
  • Elegant Design – modern and sleek appearance to enhance laboratory aesthetics
  • Network Capable – generate and save run reports automatically onto a shared local drive

MaxCyte’s ExPERT™ GTx platform provides for engineering of primary and stem cells with high efficiency and cell viability enabling:

  • improved, more powerful disease modeling
  • high efficiency gene editing (correction, deletion or insertion)
  • development of high potency, highly efficacious human therapeutics

Flow Electroporation®technology meets the stringent demands of cell & gene therapy:

  • highly efficient and reproducible transfection
  • non-toxic
  • payload flexibility
  • clinical-scale manufacturing

Platform scalability and established regulatory-compliance supports rapid and seamless advancements from concept through clinic

Supported by publications, clinical trials and 50+ partnered clinical development programs